Key result
Oncologic digestive surgery had a 23.8% incidence of surgical-site infection at 30 days, independently associated with surgery time, type, prior radiotherapy, and surgeon experience.
Why the study?
What are the incidence and risk factors for surgical-site infection in patients undergoing oncologic digestive surgery?
Cohort (n=210)
No
What are the incidence and risk factors for surgical-site infection in patients undergoing oncologic digestive surgery?
Surgical-site infection is common (23.8%) after oncologic digestive surgery and is associated with largely non-modifiable risk factors such as surgery type/time, prior radiotherapy, and surgeon experience.
Answers are grounded in this paper and cite their sources.
High SSI rates after oncologic digestive surgery warrant heightened surveillance; leaves open whether targeted interventions can mitigate largely non-modifiable risks.
Surgical-site infection (SSI) is the most prevalent type of hospital infection in surgical patients and is associated with an increase in hospital stay, costs and morbidity/lethality. The knowledge of the main risk factors for this type of infection is important for the establishment of prevention measures regarding modifiable risks factors. The objective of the preset study was to assess the occurrence of SSI and study the risk factors in oncologic surgeries of the digestive system at Hospital de Câncer in Barretos, São Paulo, Brazil. Individuals undergoing oncologic surgeries of the digestive system in the period of 08/01/2007 to 08/10/2008 were prospectively followed for 30 days after surgery. Possible risk factors related to the patient and to the surgical procedure were also studied. A total of 210 surgeries were analyzed, with a global SSI incidence of 23.8%. The following variables were independently associated with SSI: time and type of surgery, radiotherapy before surgery and surgeon's years of experience. The risk factors found in this study have been described by other authors and are not amenable to intervention for SSI prevention. Further studies are recommended with the objective of investigating interventions that could reduce the risk for SSI in this type of surgery.
No takes yet. Share an insight, caveat, or question.
Castro et al. (2011) conducted a cohort in Oncologic digestive system cancer (n=210). Oncologic digestive surgery was evaluated on Surgical-site infection (SSI). Oncologic digestive surgery had a 23.8% incidence of surgical-site infection at 30 days, independently associated with surgery time, type, prior radiotherapy, and surgeon experience.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: